Search

Search Constraints

You searched for: Author/Creator Collini, P.

Search Results

1. SELNET clinical practice guidelines for bone sarcoma. (June 2022)

2. Corrigendum to "SELNET clinical practice guidelines for bone sarcoma" Critical reviews in oncology/hematology, vol. 174 (2022), 1–10. (December 2022)

3. ISG15 as a prognostic biomarker in solitary fibrous tumour. (October 2022)

4. Tazemetostat and doxorubicin in patient-derived preclinical models of epithelioid sarcoma (ES). (October 2022)

5. Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. (May 2017)

6. Resectable extra-pleural and extra-meningeal solitary fibrous tumours: A multi-centre prognostic study. Issue 7 (July 2016)

7. Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study. (January 2019)

8. Is There a Role for FDG-PET for the Assessment of Treatment Efficacy in Wilms' Tumor? A Case Report and Literature Review. (1st October 2013)

9. Corrigendum to "SELNET clinical practice guidelines for soft tissue sarcoma and GIST" [Cancer Treat. Rev. 102 (2021) 102312]. (April 2023)

10. SELNET clinical practice guidelines for soft tissue sarcoma and GIST. (January 2022)